{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:33:29Z","timestamp":1791286409574,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572360"],"award-info":[{"award-number":["81572360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metastasis of malignant tumors accelerates systemic failure and hastens the deaths of pancreatic cancer patients. During the metastatic process, the physical translocation of cancer cells from the primary lesion to distant organs and is crucial. CSCs properties, such as self-renewal and multiple-direction differentiation capacity are essential for colonization in the microenvironment of distant organs and metastatic lesion formation. It is widely believed that EMT can cause cancer cells to penetrate blood vessels by undergoing phenotypic and cytoskeletal changes, so that they can infiltrate surrounding tissue and disseminate from the primary tumor to the blood circulation, where they are termed circulating tumor cells (CTCs), while CTCs often exhibit stemness properties. Accumulating evidence demonstrates that some EMT-related transcription factors are essential for CSCs self-renewal, so cancer cells that have undergone EMT typically acquire increased stemness properties. Abnormal activation of the WNT signaling pathway can drive a series of gene transcripts to promote EMT in multiple types of cancer, and among different Frizzled receptors of WNT signaling pathway, FZD7 expression is associated with distant organ metastasis, advanced clinical stages, and poor clinical prognosis. Objective of this study is to demonstrate that high FZD7 expression in pancreatic cancer can accelerate hepatic metastases and elucidate the related molecular mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of Frrizled receptor 7 (FZD7) in pancreatic ductal adenocarcinoma (PDAC) and relating survival rate were analyzed by bioinformatics, histochemistry assay and follow-up study. In vitro, FZD7 expression was silenced by lentiviral vectors carrying short hair RNA (shRNA) or upregulated by overexpression plasmid. Then, Wound-healing and Transwell experiment was used to analyze the abilities of migration and invasion; the levels of epithelial-to-mesenchymal transition (EMT) relating phenotype proteins, stemness relating phenotype proteins, and signaling molecular proteins were measured by Western-blot; cell stemness was evaluated by sphere forming ability of cells in suspension culture and detecting the proportion of CD24<jats:sup>+<\/jats:sup>CD44<jats:sup>+<\/jats:sup> cells with flow cytometry. TGF-\u03b21 was used to induce EMT, and observe the effect of shRNA silencing FZD7 on which.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>High level of FZD7 expression in pancreatic cancer samples was associated with earlier hepatic metastasis. In vitro upregulation FZD7 can enable pancreatic cancer cells to obtain stronger migration and invasion ability and higher mesenchymal phenotype, and vice versa; the proportion of cancer stem cell (CSC) was also positively correlated with the level of FZD7; cells forming spheres in suspension culture showed stronger migration and invasion ability and higher level of mesenchymal phenotype than normal adherent cultured cells; the level of FZD7 was positively correlated with the level of activated \u03b2-catenin. Silencing FZD7 expression can attenuate EMT induced by TGF-\u03b21 stimulating, and TGF-\u03b21 stimulating can also upregulate stemness phenotype expression, such as ABCG2, CD24, and CD44 by mediating of FZD7.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High FZD7 expression in pancreatic cancer can accelerates hepatic metastases by promoting EMT and strengthening cell stemness, and FZD7 can work through the canonical Wingless-type (WNT) signaling pathway and participate in TGF-\u03b2\/SMAD3 signaling pathway also.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-022-00509-1","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:06:59Z","timestamp":1658228819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-\u03b2\/SMAD3 signaling"],"prefix":"10.1186","volume":"28","author":[{"given":"Zhongbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-3496","authenticated-orcid":false,"given":"Yuanhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"509_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11\u201326.","journal-title":"Nat Rev Cancer"},{"key":"509_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bjc.2016.121","volume":"114","author":"JS Ankeny","year":"2016","unstructured":"Ankeny JS, Court CM, Hou S, et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Br J Cancer. 2016;114:1367\u201375.","journal-title":"Br J Cancer"},{"key":"509_CR3","doi-asserted-by":"publisher","first-page":"e1346","DOI":"10.1038\/cddis.2014.302","volume":"5","author":"M Asad","year":"2014","unstructured":"Asad M, Wong MK, Tan TZ, et al. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt\/PCP pathway. Cell Death Dis. 2014;5:e1346.","journal-title":"Cell Death Dis"},{"key":"509_CR4","doi-asserted-by":"publisher","first-page":"65957","DOI":"10.18632\/oncotarget.19586","volume":"8","author":"TT Cao","year":"2017","unstructured":"Cao TT, Xiang D, Liu BL, et al. FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma. Oncotarget. 2017;8:65957\u201368.","journal-title":"Oncotarget"},{"key":"509_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559\u201364.","journal-title":"Science"},{"key":"509_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL, San Juan BP, Lim E, et al. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645\u201354.","journal-title":"Cancer Metastasis Rev"},{"key":"509_CR7","doi-asserted-by":"crossref","unstructured":"Chakrabarti R, Wei Y, Hwang J, et al. DeltaNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing FZD7 expression and WNT signalling. Nat Cell Biol. 2014;16:1004\u20131015, 1\u201313.","DOI":"10.1038\/ncb3040"},{"key":"509_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/bjc.2016.255","volume":"115","author":"B Claudia","year":"2016","unstructured":"Claudia B, Laia C, Aristidis M. Transforming growth factor \u03b2 as regulator of cancer stemness and metastasis. Br J Cancer. 2016;115:761\u20139.","journal-title":"Br J Cancer"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12032-015-0552-8","volume":"32","author":"B Deng","year":"2015","unstructured":"Deng B, Zhang S, Miao Y, et al. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial\u2013mesenchymal transition of cervical cancer cell lines. Med Oncol. 2015;32:102.","journal-title":"Med Oncol"},{"key":"509_CR10","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1158\/0008-5472.CAN-08-4135","volume":"69","author":"TA DiMeo","year":"2009","unstructured":"DiMeo TA, Anderson K, Phadke P, et al. A novel lung metastasis signature links WNT signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res. 2009;69:5364\u201373.","journal-title":"Cancer Res"},{"key":"509_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.1061803","volume":"17","author":"G Dontu","year":"2003","unstructured":"Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells. Genes Dev. 2003;17:1253\u201370.","journal-title":"Genes Dev"},{"key":"509_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, Castro-Giner F, Szczerba BM, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176:98\u2013112.","journal-title":"Cell"},{"key":"509_CR13","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.biocel.2007.07.011","volume":"39","author":"M Guarino","year":"2007","unstructured":"Guarino M. Epithelial\u2013mesenchymal transition and tumour invasion. Int Biochem Cell Biol. 2007;39:2153\u201360.","journal-title":"Int Biochem Cell Biol"},{"key":"509_CR14","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","volume":"109","author":"A Gurney","year":"2012","unstructured":"Gurney A, Axelrod F, Bond CJ, et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA. 2012;109:11717\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"509_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1053\/j.gastro.2014.08.002","volume":"147","author":"PC Hermann","year":"2014","unstructured":"Hermann PC, Sancho P, Ca\u00f1amero M, et al. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifffferentiation of acinar cells in mice. Gastroenterology. 2014;147:1119\u201333.","journal-title":"Gastroenterology"},{"key":"509_CR16","doi-asserted-by":"publisher","first-page":"76337","DOI":"10.18632\/oncotarget.10942","volume":"7","author":"W Iqbal","year":"2016","unstructured":"Iqbal W, Alkarim S, AlHejin A, et al. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget. 2016;7:76337\u201353.","journal-title":"Oncotarget"},{"key":"509_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2015.04.018","volume":"335","author":"F Islam","year":"2015","unstructured":"Islam F, Gopalan V, Smith RA, et al. Translational potential of cancer stem cells: a review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment. Exp Cell Res. 2015a;335:135\u201347.","journal-title":"Exp Cell Res"},{"key":"509_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexmp.2015.02.002","volume":"98","author":"F Islam","year":"2015","unstructured":"Islam F, Qiao B, Smith RA, et al. Cancer stem cell: fundamental experimental pathological concepts and updates. Exp Mol Pathol. 2015b;98:184\u201391.","journal-title":"Exp Mol Pathol"},{"key":"509_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"509_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cellsig.2011.12.009","volume":"24","author":"TD King","year":"2012","unstructured":"King TD, Zhang W, Suto MJ, et al. Frizzled7 as an emerging target for cancer therapy. Cell Signal. 2012;24:846\u201351.","journal-title":"Cell Signal"},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000337106","volume":"79","author":"M Ksiazkiewicz","year":"2012","unstructured":"Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial\u2013mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology. 2012;79:195\u2013208.","journal-title":"Pathobiology"},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"3714190","DOI":"10.1155\/2017\/3714190","volume":"2017","author":"EY Lau","year":"2017","unstructured":"Lau EY, Ho NP, Lee TK. Cancer stem cells and their microenvironment: biology and therapeutic implications. Stem Cells Int. 2017;2017:3714190.","journal-title":"Stem Cells Int"},{"key":"509_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.23756","volume":"14","author":"GM Li","year":"2018","unstructured":"Li GM, Su Q, Liu HB, et al. Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt\/\u03b2-catenin pathway in gastric cancer. Int J Biol Sci. 2018;14:280\u201393.","journal-title":"Int J Biol Sci"},{"key":"509_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao M-J, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"509_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448\u201356.","journal-title":"Nat Rev Cancer"},{"key":"509_CR26","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1158\/1078-0432.CCR-16-1467","volume":"23","author":"KE Poruk","year":"2017","unstructured":"Poruk KE, Blackford AL, Weiss MJ, et al. Circulating tumor cells expressing markers of tumor-initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23:2681\u201390.","journal-title":"Clin Cancer Res"},{"key":"509_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4252\/wjsc.v7.i3.547","volume":"7","author":"CV Rao","year":"2015","unstructured":"Rao CV, Mohammed A. New insights into pancreatic cancer stem cells. World J Stem Cells. 2015;7:547\u201355.","journal-title":"World J Stem Cells"},{"key":"509_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349\u201361.","journal-title":"Cell"},{"key":"509_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","volume":"145","author":"C Scheel","year":"2011","unstructured":"Scheel C, Eaton EN, Li SHJ, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 2011;145:926\u201340.","journal-title":"Cell"},{"key":"509_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"509_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"509_CR32","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3390\/ijms19113672","volume":"19","author":"Y Tsubakihara","year":"2018","unstructured":"Tsubakihara Y, Moustakas A. Epithelial\u2013mesenchymal transition and metastasis under the control of transforming growth factor beta. Int J Mol Sci. 2018;19:3672.","journal-title":"Int J Mol Sci"},{"key":"509_CR33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/sj.bjc.6605307","volume":"101","author":"K Ueno","year":"2009","unstructured":"Ueno K, Hazama S, Mitomori S, et al. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009;101:1374\u201381.","journal-title":"Br J Cancer"},{"key":"509_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/cancers10020033","volume":"10","author":"S Valle","year":"2018","unstructured":"Valle S, Martin-Hijano L, Alcal\u00e1 S, et al. The ever-evolving concept of the cancer stem cell in pancreatic cancer. Cancers (basel). 2018;10:33.","journal-title":"Cancers (basel)"},{"key":"509_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.7150\/jca.13305","volume":"7","author":"F Wang","year":"2016","unstructured":"Wang F, Ma L, Zhang Z, et al. Hedgehog signaling regulates epithelial-mesenchymal transition in pancreatic cancer stem-like cells. J Cancer. 2016;7:408\u201317.","journal-title":"J Cancer"},{"key":"509_CR36","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness inhibiting microRNAs. Nat Cell Biol. 2009;11:1487\u201395.","journal-title":"Nat Cell Biol"},{"key":"509_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3892\/or.2020.7595","volume":"44","author":"J Yoshida","year":"2020","unstructured":"Yoshida J, Ishikawa T, Endo Y, et al. Metformin inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and liver metastasis of pancreatic cancer cells. Oncol Rep. 2020;44:371\u201381.","journal-title":"Oncol Rep"},{"key":"509_CR38","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/cam4.3819","volume":"10","author":"ZB Zhang","year":"2021","unstructured":"Zhang ZB, Xu YH, Zhao CH. Fzd7\/Wnt7b signaling contribute to stemness and chemo resistance in pancreatic cancer. Cancer Med. 2021;10:3332\u201345.","journal-title":"Cancer Med"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:22:53Z","timestamp":1658229773000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00509-1","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Ethical Committee of The First Hospital of China Medical University [Approval no. (2015)100]. All patients recruited were consent for participating this study and use of their tissue samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are consent for this study publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}